What did @alemacedos_vencedora actually say?
The caption, not the transcript, is doing all the work here. The video's audio is essentially unintelligible, a garbled translation artifact that references ice cream cakes and wedding venues. It tells us nothing clinically useful. So we are fact-checking the caption's explicit claims about GHK-Cu and Epitalon, which are specific and worth examining carefully.
The caption documents a self-described routine: a sixth dose of GHK-Cu and seventh dose of Epitalon, presented as a daily care practice. The listed benefits are sleep improvement, stable energy, mood changes, mental clarity, and antioxidant action against skin aging. These are not throwaway claims. They map onto real research areas for both peptides, which makes them worth taking seriously rather than dismissing outright.
Does the science back this up?
Partially, and with important caveats. GHK-Cu has genuine research support for skin-related effects. Epitalon's evidence base is thinner, older, and almost entirely preclinical or from a single research group.
For GHK-Cu, the antioxidant and skin-regeneration claims have actual backing. A review by Pickart and Margolina (2018, Symmetry) documented GHK-Cu's role in stimulating collagen synthesis, activating antioxidant pathways, and modulating gene expression related to tissue repair. That is real science. The skin aging angle is the strongest claim in this caption.
Epitalon is trickier. It is a synthetic tetrapeptide derived from epithalamin. Research by Khavinson and colleagues, primarily published in Russian journals in the 1990s and 2000s, suggests effects on telomerase activation and melatonin regulation, which could theoretically explain sleep and longevity benefits. But this work has not been widely replicated by independent groups in peer-reviewed Western literature. The mood, energy, and mental clarity claims for Epitalon specifically are not well-supported by human clinical data.
What did they get wrong (or right)?
They got the GHK-Cu skin antioxidant claim broadly right. That is the most defensible statement in the caption, and credit is due for not overclaiming a cure or a specific disease treatment.
The sleep and mental clarity claims for this peptide stack are where things get slippery. Epitalon does interact with the pineal gland and may influence melatonin, which connects loosely to sleep quality. But saying it produces "stable energy" and "mental clarity" is extrapolating well beyond what controlled human trials show. A 2003 study by Anisimov et al. (Neuroendocrinology Letters) showed some circadian rhythm effects in animal models. That is not the same as clinical evidence for the energy and cognitive benefits being described.
The framing of sequential daily doses as a structured routine also normalizes a practice that carries real unknowns. Neither GHK-Cu nor Epitalon has FDA-approved dosing protocols for human use in these contexts. Presenting dose six and dose seven casually, without any discussion of monitoring or medical supervision, is a meaningful omission.
What should you actually know?
GHK-Cu is one of the better-studied peptides in the anti-aging space, but most rigorous evidence is in vitro or topical, not injectable. Epitalon is genuinely interesting scientifically, but it is mostly supported by one research group's work, and that should make any careful reader cautious.
Neither peptide is FDA-approved for systemic human use. In the United States, they exist in a regulatory gray zone, often compounded by pharmacies operating under varying oversight standards. If you are considering either peptide, the conversation has to start with a physician who can order baseline labs, assess your individual risk profile, and monitor for adverse effects. Self-administered courses documented on social media are not a substitute for that process.
The claims about mood change and mental clarity are the most unsubstantiated here. Those effects may be real for some individuals, but without controlled conditions, they cannot be separated from placebo response, lifestyle factors, or simple expectation bias. A 47,000-view video presenting anecdotal benefit as routine health practice carries real influence, and that influence should be met with proportionate skepticism.